MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR) today announced that a U.S. District Court in Arizona entered judgment in Bard’s favor in its patent infringement suit against W. L. Gore & Associates. The Court ruled that Gore failed to prove that Bard’s patent number 6,436,135 was unenforceable due to inequitable conduct. As previously announced, on December 11, 2007, a jury found that Gore willfully infringed Bard’s patent through the sale of Gore’s ePTFE vascular grafts and stent-grafts, and awarded Bard $185 million in past damages.
